Vertex Pharmaceuticals (VRTX) Treasury Shares (2010 - 2025)

Vertex Pharmaceuticals' Treasury Shares history runs 16 years deep, the most recent figure standing at $2.5 million for Q4 2025.

• On a quarterly basis, Treasury Shares fell 5.28% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 5.28% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, down 5.28% from the prior year.
• Treasury Shares fell to $2.5 million in Q4 2025 per VRTX's latest filing, from $2.7 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.0 million in Q4 2023 and bottomed at $2.5 million in Q4 2025.
• The 5-year median for Treasury Shares is $2.9 million (2021), against an average of $2.8 million.
• Across the five-year window, Treasury Shares advanced 6.87% in 2021 and decreased 9.25% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $2.9 million in 2021, then gained by 0.14% to $2.9 million in 2022, then grew by 1.68% to $3.0 million in 2023, then slipped by 9.25% to $2.7 million in 2024, then retreated by 5.28% to $2.5 million in 2025.
• Per Business Quant, the three latest VRTX Treasury Shares figures stand at $2.5 million (Q4 2025), $2.7 million (Q4 2024), and $3.0 million (Q4 2023).